• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.

作者信息

De Souza Andre, Tavora Fabio A, Mahalingam Devalingam, Munster Pamela N, Safran Howard P, El-Deiry Wafik S, Carneiro Benedito A

机构信息

Division of Hematology/Oncology, Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI, United States.

Argos Laboratory, Fortaleza, Brazil.

出版信息

Front Immunol. 2020 Oct 19;11:595289. doi: 10.3389/fimmu.2020.595289. eCollection 2020.

DOI:10.3389/fimmu.2020.595289
PMID:33193448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7604263/
Abstract
摘要

相似文献

1
Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.评论：抑制糖原合成酶激酶-3作为对抗严重急性呼吸综合征冠状病毒2的治疗方法：抑制病毒复制同时增强免疫反应的双重益处。
Front Immunol. 2020 Oct 19;11:595289. doi: 10.3389/fimmu.2020.595289. eCollection 2020.
2
GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.GSK-3 抑制作为一种治疗 SARS-CoV-2 的方法：抑制病毒复制和增强免疫反应的双重益处。
Front Immunol. 2020 Jun 26;11:1638. doi: 10.3389/fimmu.2020.01638. eCollection 2020.
3
TNF-α expression in neutrophils and its regulation by glycogen synthase kinase-3: a potentiating role for lithium.中性粒细胞中肿瘤坏死因子-α的表达及其受糖原合酶激酶-3的调控：锂的增强作用。
FASEB J. 2014 Aug;28(8):3679-90. doi: 10.1096/fj.14-251900. Epub 2014 May 6.
4
Inhibitory effect of polycations on phosphorylation of glycogen synthase by glycogen synthase kinase 3.聚阳离子对糖原合酶激酶3介导的糖原合酶磷酸化的抑制作用。
Biochim Biophys Acta. 1989 May 10;1011(2-3):198-204. doi: 10.1016/0167-4889(89)90210-3.
5
Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.糖原合酶激酶-3β抑制剂通过抑制核因子-κB 活化抑制牙龈卟啉单胞菌脂多糖诱导的小鼠成骨细胞 CD40 表达。
Mol Immunol. 2012 Aug;52(1):38-49. doi: 10.1016/j.molimm.2012.04.005. Epub 2012 May 14.
6
Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging.糖原合酶激酶-3（GSK-3）靶向治疗与成像
Theranostics. 2016 Feb 17;6(4):571-93. doi: 10.7150/thno.14334. eCollection 2016.
7
Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.抑制糖原合酶激酶-3β可改善肥厚心脏对缺血的耐受性。
Ann Thorac Surg. 2007 Jul;84(1):126-33. doi: 10.1016/j.athoracsur.2007.02.015.
8
Inhibition of glycogen synthase kinase-3β enhances cognitive recovery after stroke: the role of TAK1.糖原合酶激酶-3β的抑制增强中风后的认知恢复：转化生长因子β激活激酶1的作用
Learn Mem. 2015 Jun 15;22(7):336-43. doi: 10.1101/lm.038083.115. Print 2015 Jul.
9
Identification and in vitro evaluation of new leads as selective and competitive glycogen synthase kinase-3β inhibitors through ligand and structure based drug design.通过基于配体和结构的药物设计，鉴定新型先导化合物作为选择性和竞争性糖原合酶激酶-3β抑制剂并进行体外评估。
J Mol Graph Model. 2014 Sep;53:31-47. doi: 10.1016/j.jmgm.2014.06.013. Epub 2014 Jul 12.
10
Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer's disease.新开发的糖原合酶激酶-3（GSK-3）抑制剂可保护淀粉样β诱导的细胞模型和阿尔茨海默病转基因小鼠模型中的神经元细胞死亡。
Biochem Biophys Res Commun. 2013 May 31;435(2):274-81. doi: 10.1016/j.bbrc.2013.04.065. Epub 2013 Apr 28.

引用本文的文献

1
Enzymes in the time of COVID-19: An overview about the effects in the human body, enzyme market, and perspectives for new drugs.新冠疫情期间的酶：对人体影响、酶市场及新药前景的概述。
Med Res Rev. 2022 Nov;42(6):2126-2167. doi: 10.1002/med.21919. Epub 2022 Jun 28.
2
Impact of SARS-CoV-2 on Host Factors Involved in Mental Disorders.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）对精神障碍相关宿主因素的影响。
Front Microbiol. 2022 Apr 4;13:845559. doi: 10.3389/fmicb.2022.845559. eCollection 2022.

本文引用的文献

1
Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations.COVID-19 致死病例的完整尸检数据：临床、影像学和病理学相关性。
Int J Legal Med. 2020 Nov;134(6):2209-2214. doi: 10.1007/s00414-020-02390-1. Epub 2020 Aug 6.
2
Fatal pulmonary fibrosis: a post-COVID-19 autopsy case.致命性肺纤维化：1例COVID-19后尸检病例
J Clin Pathol. 2020 Jul 28. doi: 10.1136/jclinpath-2020-206879.
3
GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.GSK-3 抑制作为一种治疗 SARS-CoV-2 的方法：抑制病毒复制和增强免疫反应的双重益处。
Front Immunol. 2020 Jun 26;11:1638. doi: 10.3389/fimmu.2020.01638. eCollection 2020.
4
[Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].严重急性呼吸综合征与2019冠状病毒病的临床和病理特征比较
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jun 12;43(6):496-502. doi: 10.3760/cma.j.cn112147-20200311-00312.
5
Glycogen Synthase Kinase-3β Inhibition with 9-ING-41 Attenuates the Progression of Pulmonary Fibrosis.9-ING-41 通过抑制糖原合酶激酶-3β减轻肺纤维化进展。
Sci Rep. 2019 Dec 12;9(1):18925. doi: 10.1038/s41598-019-55176-w.
6
Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage Response.糖原合酶激酶-3 抑制通过消除 TopBP1/ATR 介导的 DNA 损伤反应使胰腺癌细胞对化疗敏感。
Clin Cancer Res. 2019 Nov 1;25(21):6452-6462. doi: 10.1158/1078-0432.CCR-19-0799. Epub 2019 Sep 18.
7
Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses.糖原合酶激酶-3β抑制剂作为新型癌症治疗药物和抗肿瘤免疫反应调节剂。
Cancer Biol Ther. 2019;20(8):1047-1056. doi: 10.1080/15384047.2019.1595283. Epub 2019 Apr 12.
8
Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy.小分子抑制 PD-1 转录是癌症治疗中抗体阻断的有效替代方法。
Cancer Res. 2018 Feb 1;78(3):706-717. doi: 10.1158/0008-5472.CAN-17-0491. Epub 2017 Oct 20.
9
Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.糖原合酶激酶3失活驱动T-bet介导的共受体PD-1下调以增强CD8(+) 细胞毒性T细胞反应。
Immunity. 2016 Feb 16;44(2):274-86. doi: 10.1016/j.immuni.2016.01.018.
10
Inhibition of glycogen synthase kinase (GSK)-3-β improves liver microcirculation and hepatocellular function after hemorrhagic shock.抑制糖原合酶激酶（GSK）-3-β可改善失血性休克后的肝脏微循环和肝细胞功能。
Eur J Pharmacol. 2014 Feb 5;724:175-84. doi: 10.1016/j.ejphar.2013.12.029. Epub 2014 Jan 2.